Page 134 - HRC_AR2020
P. 134

132    I     2020 ANNUAL REPORT         I financial reports


            NOTES TO THE FINANCIAL STATEMENTS

            FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2020 (CONTINuED)





             33  DiViDenDs

                  On 26 February 2021, the Directors declared a single-tier interim dividend of RM0.04 per share, amounting to RM12,000,000
                  in respect of the financial year ended 31 December 2020. The dividend is payable on 15 April 2021 to shareholders registered
                  on the Record of Depositors at the close of business on 23 March 2021. These financial statements do not reflect the interim
                  dividend which will be accounted for in the financial year ending 31 December 2021.
                  The Company did not declare any dividend for the financial year ended 31 December 2019.

             34  siGnificant eVent
                  The Company has recorded 43.2% lower revenue in 2020 as compared to 2019, mainly due to the lower sales volume
                  coupled with lower quoted product prices resulted from the implementation of lockdown and travel restrictions in Malaysia
                  as well as globally. Notwithstanding the unprecedented challenges faced, the hedging strategy undertaken by the Company
                  has protected the Company’s gross profit margin and uplifted the gross profit margin. To manage liquidity, the Company has
                  utilised the existing financing facilities and obtained additional accounts receivable factoring facility as disclosed in Note 4(c).
                  Based on the liquidity assessment performed for the next 12 months from the reporting date, the Directors concluded that
                  the Company would have sufficient cash flows to fulfill its obligations and finance its ongoing operations. The Company has
                  also carried out an impairment review on the refinery assets and an assessment on the net realisable value of its hydrocarbon
                  inventories in view of the impact of COVID-19 on the business activities. The result of the assessments are set out in Note 3(a)
                  and Note 3(c).
                  The rollout of global COVID-19 vaccination program has raised the hopes for the turnaround in the pandemic in 2021.
                  However, the potential renewed waves and the virus mutations may continue to loom the world’s economies with uncertainties.
                  The Company will continue to monitor the situation, take appropriate and timely actions to minimise the impact brought by
                  the pandemic in order to ensure the sustainability of the business.

             35  approVal of financial stateMents

                  The financial statements have been approved for issue in accordance with a resolution of the Board of Directors on
                  26 March 2021.
   129   130   131   132   133   134   135   136   137   138   139